(Total Views: 753)
Posted On: 02/24/2021 5:11:33 PM
Post# of 72446
Here is a post by JFM on IFUD this morning that got deleted... Interesting read and I believe it could be fairly accurate......
Quote:
The Captain of our ship is Leo Ehrlich whom we rely on to steer us to reap the rewards of a successful Brilacidin trial for COVID-19. That’s right the same drug he bought for $5million.
...an astute and some would say "genius" move!
Leo's new "stealth" approach to releasing minimal information (via disclosure in 10Q) could be pointing (speculating) to another...ASTUTE MOVE...and more positive news on the horizon.
The question becomes what has caused Leo to radically modify his M.O. ... not doing a traditional expansive PR, on obviously good news (commencement of trials in U.S. and Russia). The anwer might be in four questions...
1. Could the LEO M.O change due to stategic calculated shift? Likely...another clever move...Keep the details close to the vest...and naked and legal shorts in the dark...until BOOM! Brilacidin explodes onto the scene...OK good...but there could be more..
2. Could the regulatory authority (FDA) desire to keep the information on trial developments and their results...under wraps because they know how explosive and fundamentally ground-breaking in the treatment of all viruses and bacteria?
3. Could IPIX be in a quiet period by agreemengt, while negotiating with BP on all or part of a deal involving Brilacidin (or entire company)?
4. Could we be witnessing a combination of 2 & 3?
IMO...we will see $2.00 (and likely much more) before and if ever, we see $0.20 again
...of course all IMO
Quote:
The Captain of our ship is Leo Ehrlich whom we rely on to steer us to reap the rewards of a successful Brilacidin trial for COVID-19. That’s right the same drug he bought for $5million.
...an astute and some would say "genius" move!
Leo's new "stealth" approach to releasing minimal information (via disclosure in 10Q) could be pointing (speculating) to another...ASTUTE MOVE...and more positive news on the horizon.
The question becomes what has caused Leo to radically modify his M.O. ... not doing a traditional expansive PR, on obviously good news (commencement of trials in U.S. and Russia). The anwer might be in four questions...
1. Could the LEO M.O change due to stategic calculated shift? Likely...another clever move...Keep the details close to the vest...and naked and legal shorts in the dark...until BOOM! Brilacidin explodes onto the scene...OK good...but there could be more..
2. Could the regulatory authority (FDA) desire to keep the information on trial developments and their results...under wraps because they know how explosive and fundamentally ground-breaking in the treatment of all viruses and bacteria?
3. Could IPIX be in a quiet period by agreemengt, while negotiating with BP on all or part of a deal involving Brilacidin (or entire company)?
4. Could we be witnessing a combination of 2 & 3?
IMO...we will see $2.00 (and likely much more) before and if ever, we see $0.20 again
...of course all IMO
(11)
(0)
